Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary- an experience in Taiwan

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Chang, Morgan F ^a   Wang, Hung Ming ^b,c   Kang, Chung Jan ^b   Huang, Shiang Fu ^b   Lin, Chien Yu ^b,c   Fang, Kang Hsing ^b,c   Chen, Eric Y ^b   Chen, I How ^b   Liao, Chun Ta ^b   Chang, Joseph T ^b,c  

^a Hsinchu General Hospital   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FOLINIC ACID; TEGAFUR; ANTINEOPLASTIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HYPOPHARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; SECOND CANCER; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TAIWAN; TREATMENT OUTCOME; ABDOMINAL SURGERY; ADOLESCENT; AGED; CANCER STAGING; HYPOPHARYNX TUMOR; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; TAIWAN; TEGAFUR; YOUNG ADULT;

EID: 77957360232     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-91     Document Type: Article

References (33)

1. Lajtman Z, Manestar D. A comparison of surgery and radiotherapy in the management of advanced pyriform fossa carcinoma. Clin Otolaryngol Allied Sci 2001, 26:59-61. 10.1046/j.1365-2273.2001.00430.x, 11298170.
2. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, Wolden SL, Narayana A, Kraus D, Shah JP, Pfister DG. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007, 69:459-468.
3. Arriagada R, Eschwege F, Cachin Y, Richard JM. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983, 51:1819-1825. 10.1002/1097-0142(19830515)51:10<1819::AID-CNCR2820511011>3.0.CO;2-G, 6831347.
4. Soo KC, Tan EH, Wee J, Lim D, Tai BC, Khoo ML, Goh C, Leong SS, Tan T, Fong KW, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005, 93:279-286. 10.1038/sj.bjc.6602696, 2361563, 16012523.
5. Sewnaik A, Hoorweg JJ, Knegt PP, Wieringa MH, van der Beek JM, Kerrebijn JD. Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period. Clin Otolaryngol 2005, 30:52-57. 10.1111/j.1365-2273.2004.00913.x, 15748191.
6. Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 2005, 23:88-95. 10.1200/JCO.2005.04.017, 15625363.
7. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004, 130:861-867. 10.1001/archotol.130.7.861, 15262764.
8. Robbins KT, Fontanesi J, Wong FS, Vicario D, Seagren S, Kumar P, Weisman R, Pellitteri P, Thomas JR, Flick P, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996, 122:853-857.
9. Rudat V, Pfreundner L, Hoppe F, Dietz A. Approaches to preserve larynx function in locally advanced laryngeal and hypopharyngeal cancer. Onkologie 2004, 27:368-375. 10.1159/000079090, 15347892.
10. Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, Spiro RH, Bosl GJ, Harrison LB. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1996, 18:405-411. 10.1002/(SICI)1097-0347(199609/10)18:5<405::AID-HED3>3.0.CO;2-9, 8864731.
11. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991, 324:1685-1690. 10.1056/NEJM199106133242402, 2034244.
12. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890-899. 10.1093/jnci/88.13.890, 8656441.
13. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355:949-955.
14. Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD, Damm C, Carter SG, Hines JD. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 1990, 65:1685-1691. 10.1002/1097-0142(19900415)65:8<1685::AID-CNCR2820650804>3.0.CO;2-S, 2317751.
15. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081-2086. 10.1093/jnci/91.24.2081, 10601378.
16. Wang HM, Wang CS, Chen JS, Chen IH, Liao CT, Chang TC. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 2002, 94:2989-2995. 10.1002/cncr.10570, 12115388.
17. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975, 2:177-191. 10.1016/S0305-7372(75)80002-8, 1104162.
18. Featherstone CJ, Clarke S, Jackson MA, Shannon KF, McNeil EB, Tin MM, Clifford A, O'Brien CJ. Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation. ANZ J Surg 2004, 74:554-558. 10.1111/j.1445-2197.2004.03056.x, 15230789.
19. Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, et al. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 2004, 22:2856-2864. 10.1200/JCO.2004.12.012, 15254053.
20. Kim JG, Sohn SK, Kim DH, Baek JH, Jeon SB, Chae YS, Lee KB, Park JS, Sohn JH, Kim JC, Park IK. Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 2005, 93:1117-1121. 10.1038/sj.bjc.6602849, 2361495, 16251869.
21. Lavertu P, Adelstein DJ, Saxton JP, Secic M, Eliachar I, Strome M, Larto MA, Wood BG. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999, 125:142-148.
22. Razack MS, Sako K, Marchetta FC, Calamel P, Bakamjian V, Shedd DP. Carcinoma of the hypopharynx: success and failure. Am J Surg 1977, 134:489-491. 10.1016/0002-9610(77)90383-X, 911032.
23. Rudat V, Wannenmacher M. Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer. Semin Surg Oncol 2001, 20:66-74. 10.1002/ssu.1018, 11291134.
24. Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006, 24:1064-1071. 10.1200/JCO.2005.01.5867, 16505425.
25. Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck 2004, 26:561-572. 10.1002/hed.20012, 15229898.
26. Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, et al. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Int J Radiat Oncol Biol Phys 2004, 59:481-487.
27. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098. 10.1056/NEJMoa031317, 14645636.
28. Studer G, Lutolf UM, Davis JB, Glanzmann C. IMRT in hypopharyngeal tumors. Strahlenther Onkol 2006, 182:331-335. 10.1007/s00066-006-1556-2, 16703288.
29. Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, Glanzmann C. Surviving hypopharynx-larynx carcinoma in the era of IMRT. Int J Radiat Oncol Biol Phys 77:1391-1396.
30. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, Marsh R, Pameijer FA, Balm AJ. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004, 60:1425-1439.
31. Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 2003, 129:733-738. 10.1001/archotol.129.7.733, 12874074.
32. Department of Health the Executive Yuan, February 2010. Cancer registry: annual report in Taiwan area in 2007. Department of Health.
33. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6:963-968. 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q, 13094644.